Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIA1 | P42261 | 1/20 | 0.43 |
| ▸ | CACNG8 | Q8WXS5 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 2/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | GLA | P06280 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL308199 | 0.76 | CYP2A6 (0.55) | GRIA1CACNG8CYP2A6ALDH1A1MAPT | |
| SCHEMBL21881930 | 0.75 | AKT2 (0.43) | ATMALDH1A1MAPTKMT2ALMNA | |
| SCHEMBL14886625 | 0.74 | RXRA (0.53) | GRIA1CACNG8TSHR | |
| SCHEMBL2932603 | 0.74 | AHR (0.52) | CYP2A6ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL528504 | 0.73 | GABRA1 (0.39) | ATMCYP2A6ALDH1A1MAPTMEN1 | |
| SCHEMBL15543810 | 0.73 | ALDH1A1 (0.41) | ATMCYP2A6ALDH1A1MAPTMEN1 | |
| SCHEMBL16939188 | 0.72 | ESR2 (0.52) | CYP2A6ALDH1A1MAPTMEN1KMT2A | |
| Hydrogen Sulfide SCHEMBL11666785 | 0.72 | AHR (0.50) | CYP2A6ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL5331238 | 0.72 | ATM (0.63) | ATMCYP2A6ALDH1A1MAPTMEN1 | |
| SCHEMBL1524405 | 0.72 | CYP2A6 (0.45) | ATMCYP2A6ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 252 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026090602-A1 | PIGMENTED RESIN AND CATALYST COMPOSITIONS | MATERIA, INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| EP-3110862-B1 | ADHESION PROMOTER COMPOSITIONS FOR CYCLIC OLEFIN RESIN COMPOSITIONS | ExxonMobil Product Solutions Company (US) | 2026-04-01 | — | — | EP | disclosed |
| EP-4683900-A2 | ROMP AND THERMAL INSULATION COMPOSITIONS AND MATERIALS AND USE THEREOF | Materia, Inc. (US) | 2026-01-28 | — | — | EP | disclosed |
| WO-2025245037-A1 | CYCLIC OLEFIN COMPOSITIONS, ROMP COMPOSITIONS THEREOF, AND APPLICATIONS THEREOF | MATERIA, INC. (US) | 2025-11-27 | — | — | WO | disclosed |
| EP-4194092-B1 | SYNTHESIS AND CHARACTERIZATION OF METATHESIS CATALYSTS | UMICORE AG & CO KG (DE) | 2025-10-22 | — | — | EP | disclosed |
| EP-2970522-B1 | IN-MOLD COATING OF ROMP POLYMERS | MATERIA INC (US) | 2025-05-21 | — | — | EP | disclosed |
| EP-3013886-B1 | THERMAL INSULATION | MATERIA INC (US) | 2025-03-26 | — | — | EP | disclosed |
| EP-2961778-B1 | METAL CARBENE OLEFIN METATHESIS TWO CATALYST COMPOSITION | MATERIA INC (US) | 2025-02-26 | — | — | EP | disclosed |
| US-20250026871-A1 | CYCLIC RUTHENIUM BENZYLIDENE INITIATORS FOR ENHANCED RING EXPANSION METATHESIS POLYMERIZATION | UNIVERSITY OF WASHINGTON (US) | 2025-01-23 | — | — | US | disclosed |
| EP-4455207-A2 | LIQUID MOLDING COMPOSITIONS | Materia, Inc. (US) | 2024-10-30 | — | — | EP | disclosed |
| WO-2008008440-A2 | RING OPENING CROSS-METATHESIS REACTION OF CYCLIC OLEFINS WITH SEED OILS AND THE LIKE | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2008-01-17 | — | — | WO | disclosed |
| EP-1497299-A4 | CROSS-METATHESIS OF OLEFINS DIRECTLY SUBSTITUTED WITH AN ELECTRON-WITHDRAWING GROUP USING TRANSITION METAL CARBENE CATALYSTS | CALIFORNIA INST OF TECHN (US) | 2006-08-02 | — | — | EP | disclosed |
| EP-1543043-A4 | SYNTHESIS OF MACROCYCLIC POLYMERS BY RING INSERTION POLYMERIZATION OF CYCLIC OLEFIN MONOMERS | CALIFORNIA INST OF TECHN (US) | 2005-11-02 | — | — | EP | disclosed |
| US-6946533-B2 | Synthesis of macrocyclic polymers by ring insertion polymerization of cyclic olefin monomers | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2005-09-20 | — | — | US | disclosed |
| EP-1543043-A2 | SYNTHESIS OF MACROCYCLIC POLYMERS BY RING INSERTION POLYMERIZATION OF CYCLIC OLEFIN MONOMERS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2005-06-22 | — | — | EP | disclosed |
| EP-1497299-A2 | CROSS-METATHESIS OF OLEFINS DIRECTLY SUBSTITUTED WITH AN ELECTRON-WITHDRAWING GROUP USING TRANSITION METAL CARBENE CATALYSTS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2005-01-19 | — | — | EP | disclosed |
| US-20040132934-A1 | Synthesis of macrocyclic polymers by ring insertion polymerization of cyclic olefin monomers | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2004-07-08 | — | — | US | disclosed |
| WO-2004013198-A2 | SYNTHESIS OF MACROCYCLIC POLYMERS BY RING INSERTION POLYMERIZATION OF CYCLIC OLEFIN MONOMERS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2004-02-12 | — | — | WO | disclosed |
| US-20030236427-A1 | Cross-metathesis of olefins directly substituted with an electron-withdrawing group using transition metal carbene catalysts | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-12-25 | — | — | US | disclosed |
| WO-2003087167-A2 | CROSS-METATHESIS OF OLEFINS DIRECTLY SUBSTITUTED WITH AN ELECTRON-WITHDRAWING GROUP USING TRANSITION METAL CARBENE CATALYSTS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2003-10-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030236427-A1 | Cross-metathesis of olefins directly substituted with an electron-withdrawing group using transition metal carbene catalysts | OXER1, DUOX2, AOC2 | GRIA1 998/4885CACNG8 1074/4885ATM 1627/4885 |
| US-20250026871-A1 | CYCLIC RUTHENIUM BENZYLIDENE INITIATORS FOR ENHANCED RING EXPANSION METATHESIS POLYMERIZATION | MCM7, MCM4, MCM5 | GRIA1 2907/4885CACNG8 1963/4885ATM 2945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.